Published in Ann Rheum Dis on July 01, 1995
High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis Res Ther (2003) 1.09
Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res (2000) 1.06
Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro. Ann Rheum Dis (1998) 0.88
Vitamin E slows down the progression of osteoarthritis. Exp Ther Med (2016) 0.75
New concepts about the mast cell. N Engl J Med (1993) 3.43
TNF alpha--a pivotal role in rheumatoid arthritis? Br J Rheumatol (1992) 2.34
Mast cells at sites of cartilage erosion in the rheumatoid joint. Ann Rheum Dis (1984) 1.94
Regulation and deregulation of human IgE synthesis. Immunol Today (1990) 1.58
The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol (1993) 1.55
Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion. Ann Rheum Dis (1995) 1.37
Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur J Biochem (1994) 1.37
Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine. Arthritis Rheum (1986) 1.31
Mast cells and fibrosis--who's on first? Am J Respir Cell Mol Biol (1993) 0.94
Characterization of human synovial mast cells. J Rheumatol (1988) 0.92
IgE antibodies specific for cartilage collagens type II, IX and XI in rheumatic diseases. Scand J Rheumatol (1993) 0.84